Logo image of ACNT

ASCENT INDUSTRIES CO (ACNT) Stock Fundamental Analysis

NASDAQ:ACNT - Nasdaq - US8715651076 - Common Stock - Currency: USD

12.97  -0.04 (-0.31%)

Fundamental Rating

3

Overall ACNT gets a fundamental rating of 3 out of 10. We evaluated ACNT against 154 industry peers in the Metals & Mining industry. While ACNT has a great health rating, there are worries on its profitability. ACNT is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year ACNT has reported negative net income.
In the past year ACNT had a positive cash flow from operations.
In multiple years ACNT reported negative net income over the last 5 years.
In the past 5 years ACNT always reported a positive cash flow from operatings.
ACNT Yearly Net Income VS EBIT VS OCF VS FCFACNT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M 30M

1.2 Ratios

Looking at the Return On Assets, with a value of -6.82%, ACNT is doing worse than 66.88% of the companies in the same industry.
ACNT has a worse Return On Equity (-11.41%) than 63.64% of its industry peers.
Industry RankSector Rank
ROA -6.82%
ROE -11.41%
ROIC N/A
ROA(3y)-5.78%
ROA(5y)-4.58%
ROE(3y)-7.62%
ROE(5y)-7.75%
ROIC(3y)N/A
ROIC(5y)N/A
ACNT Yearly ROA, ROE, ROICACNT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30

1.3 Margins

ACNT has a Gross Margin (15.37%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of ACNT has grown nicely.
ACNT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 15.37%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.87%
GM growth 5Y4.26%
ACNT Yearly Profit, Operating, Gross MarginsACNT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

More info and screens

8

2. Health

2.1 Basic Checks

ACNT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ACNT has been reduced compared to 1 year ago.
The number of shares outstanding for ACNT has been increased compared to 5 years ago.
Compared to 1 year ago, ACNT has an improved debt to assets ratio.
ACNT Yearly Shares OutstandingACNT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ACNT Yearly Total Debt VS Total AssetsACNT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

ACNT has an Altman-Z score of 3.10. This indicates that ACNT is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of ACNT (3.10) is better than 60.39% of its industry peers.
The Debt to FCF ratio of ACNT is 0.12, which is an excellent value as it means it would take ACNT, only 0.12 years of fcf income to pay off all of its debts.
ACNT has a Debt to FCF ratio of 0.12. This is amongst the best in the industry. ACNT outperforms 94.16% of its industry peers.
A Debt/Equity ratio of 0.01 indicates that ACNT is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.01, ACNT is in the better half of the industry, outperforming 75.32% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.12
Altman-Z 3.1
ROIC/WACCN/A
WACC9.97%
ACNT Yearly LT Debt VS Equity VS FCFACNT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

A Current Ratio of 2.95 indicates that ACNT has no problem at all paying its short term obligations.
ACNT's Current ratio of 2.95 is fine compared to the rest of the industry. ACNT outperforms 64.94% of its industry peers.
ACNT has a Quick Ratio of 2.60. This indicates that ACNT is financially healthy and has no problem in meeting its short term obligations.
ACNT has a Quick ratio of 2.60. This is in the better half of the industry: ACNT outperforms 70.78% of its industry peers.
Industry RankSector Rank
Current Ratio 2.95
Quick Ratio 2.6
ACNT Yearly Current Assets VS Current LiabilitesACNT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

0

3. Growth

3.1 Past

ACNT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 96.22%, which is quite impressive.
Looking at the last year, ACNT shows a decrease in Revenue. The Revenue has decreased by -6.70% in the last year.
Measured over the past years, ACNT shows a very negative growth in Revenue. The Revenue has been decreasing by -10.24% on average per year.
EPS 1Y (TTM)96.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.19%
Revenue 1Y (TTM)-6.7%
Revenue growth 3Y-19%
Revenue growth 5Y-10.24%
Sales Q2Q%-43.94%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y229.52%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.79%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ACNT Yearly Revenue VS EstimatesACNT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
ACNT Yearly EPS VS EstimatesACNT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2023 2024 2025 0 1 -1 -2 -3 -4

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

ACNT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
ACNT is valuated correctly with a Price/Forward Earnings ratio of 15.89.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ACNT is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of ACNT to the average of the S&P500 Index (22.30), we can say ACNT is valued slightly cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 15.89
ACNT Price Earnings VS Forward Price EarningsACNT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60

4.2 Price Multiples

ACNT's Enterprise Value to EBITDA is on the same level as the industry average.
ACNT's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ACNT is cheaper than 90.91% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.43
EV/EBITDA 15.96
ACNT Per share dataACNT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ACNT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ASCENT INDUSTRIES CO

NASDAQ:ACNT (6/3/2025, 4:04:01 PM)

12.97

-0.04 (-0.31%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)05-12 2025-05-12/amc
Earnings (Next)08-04 2025-08-04/amc
Inst Owners44.93%
Inst Owner ChangeN/A
Ins Owners13.68%
Ins Owner Change3.19%
Market Cap123.22M
Analysts85.71
Price TargetN/A
Short Float %0.24%
Short Ratio0.21
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-116.34%
Min EPS beat(2)-165.36%
Max EPS beat(2)-67.32%
EPS beat(4)1
Avg EPS beat(4)-88.41%
Min EPS beat(4)-212.04%
Max EPS beat(4)91.09%
EPS beat(8)1
Avg EPS beat(8)-352.99%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-32.24%
Min Revenue beat(2)-50.42%
Max Revenue beat(2)-14.07%
Revenue beat(4)0
Avg Revenue beat(4)-24.51%
Min Revenue beat(4)-50.42%
Max Revenue beat(4)-8.54%
Revenue beat(8)1
Avg Revenue beat(8)-20.06%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 15.89
P/S 0.78
P/FCF 10.43
P/OCF 8.98
P/B 1.35
P/tB 1.46
EV/EBITDA 15.96
EPS(TTM)-0.17
EYN/A
EPS(NY)0.82
Fwd EY6.29%
FCF(TTM)1.24
FCFY9.58%
OCF(TTM)1.44
OCFY11.13%
SpS16.68
BVpS9.6
TBVpS8.89
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.82%
ROE -11.41%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 15.37%
FCFM 7.45%
ROA(3y)-5.78%
ROA(5y)-4.58%
ROE(3y)-7.62%
ROE(5y)-7.75%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.87%
GM growth 5Y4.26%
F-Score6
Asset Turnover1.04
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.12
Debt/EBITDA 0.14
Cap/Depr 27.41%
Cap/Sales 1.2%
Interest Coverage N/A
Cash Conversion 197.78%
Profit Quality N/A
Current Ratio 2.95
Quick Ratio 2.6
Altman-Z 3.1
F-Score6
WACC9.97%
ROIC/WACCN/A
Cap/Depr(3y)34.33%
Cap/Depr(5y)30.57%
Cap/Sales(3y)1.26%
Cap/Sales(5y)1.14%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)96.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.19%
EPS Next Y229.52%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-6.7%
Revenue growth 3Y-19%
Revenue growth 5Y-10.24%
Sales Q2Q%-43.94%
Revenue Next Year6.79%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y99.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year361.19%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-14.49%
FCF growth 3Y-10.03%
FCF growth 5Y-11.9%
OCF growth 1Y-26.17%
OCF growth 3Y-8.33%
OCF growth 5Y-12.51%